Cabaletta Bio, Inc. · NASDAQ:CABA
Bain Capital Life Sciences Opportunities III, LP reported a 9.99% stake in Cabaletta Bio, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Bain Capital Life Sciences Opportunities III, LP reported a 9.99% stake in Cabaletta Bio, Inc., 17,241,445 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 17,241,445
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bain Capital Life Sciences Opportunities III, LP | 9.99% | 17,241,445 |
Source
Related
- Cabaletta Bio, Inc.
- Bain Capital Life Sciences Opportunities III, LP
- Cabaletta Bio, Inc. shareholders
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2025
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Norges Bank · Aug 12, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026